Aleksandar Murgaski

Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery

D. Laoui, Aleksandar Murgaski, Pauline Bardet, 2019, Cancers.

Inflammasome- and gasdermin D-independent IL-1β production mobilizes neutrophils to inhibit antitumor immunity

D. Lambrechts, M. Mazzone, J. Qian, 2020, bioRxiv.

IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D

D. Lambrechts, L. Boon, M. Mazzone, 2020, Cancer Immunology Research.

Macrophages are metabolically heterogeneous within the tumor microenvironment.

Y. Saeys, R. De Rycke, C. Gysemans, 2020, Cell reports.

Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors.

N. Devoogdt, Evangelia Bolli, K. Movahedi, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment

C. Goyvaerts, J. V. Van Ginderachter, A. Talebi, 2022, Frontiers in Immunology.

Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy

D. Laoui, M. Kiss, Aleksandar Murgaski, 2018, Front. Immunol..

Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy

L. Boon, C. Ries, S. Janssens, 2021, bioRxiv.

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

F. Tacke, L. Boon, B. Neyns, 2021, Journal for ImmunoTherapy of Cancer.

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages

L. Boon, C. Ries, S. Janssens, 2022, Cancer research.

Macrophages are metabolically heterogeneous within the tumor microenvironment.

Y. Saeys, R. De Rycke, C. Gysemans, 2021, Cell reports.